AgeX Therapeutics, Inc. Contracts & Agreements

83 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities
AgeX Therapeutics, Inc.
Biotechnology
2025
Capital on Demand™ Sales Agreement, dated as of April 25, 2025, by and between the Company and JonesTrading Institutional Services LLC
Sales Agreements
AgeX Therapeutics, Inc.
Biotechnology
2025
Securities Purchase Agreement
Purchase Agreements
AgeX Therapeutics, Inc.
Biotechnology
2025
Agreement, dated November 26, 2024, between Serina Therapeutics, Inc. and Juvenescence Limited
AgeX Therapeutics, Inc.
Biotechnology
2025
Stock Purchase Agreement dated December 23, 2024, between Serina Therapeutics, Inc. and Juvenescence Limited
Stock Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2024
Serina Therapeutics
AgeX Therapeutics, Inc.
Biotechnology
DE
2024
Confidential Consulting Agreement, dated as of May 31, 2024, by and between Serina Therapeutics, Inc. and FLG Partners, LLC
Consulting Agreements
AgeX Therapeutics, Inc.
Biotechnology
CA
2024
Employment Agreement, dated as of July 15, 2024, by and between Serina Therapeutics, Inc. and Srini Tenjarla
Employment Agreements
AgeX Therapeutics, Inc.
Biotechnology
AL
2024
Employment Agreement, effective as of September 9, 2024, among Serina Therapeutics, Inc., Serina Therapeutics (AL), Inc. and Steve Ledger
Employment Agreements
AgeX Therapeutics, Inc.
Biotechnology
AL
2024
Eighth Amendment to Amended and Restated Convertible Promissory Note dated May 8, 2024, between UniverXome Bioengineering, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2024
Executive Chairman Agreement
AgeX Therapeutics, Inc.
Biotechnology
DE
2024
Form of Stock Option Agreement
Stock Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2024
Serina Therapeutics, Inc. 2017 Stock Option Plan
Stock Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2024
Director Compensation Policy
Compensation Agreements
AgeX Therapeutics, Inc.
Biotechnology
2024
Form of Indemnification Agreement for Officers and Directors
Indemnification Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2024
Asset Contribution Agreement dated March 26, 2024 between AgeX Therapeutics, Inc. and UniverXome Bioengineering, Inc
Contribution Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2024
Agreement with respect to Convertible Notes dated March 26, 2024, among AgeX Therapeutics, Inc., UniverXome Bioengineering, Inc., the Subsidiary Obligors and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
2024
Allonge and Seventh Amendment to Amended and Restated Convertible Promissory Notes dated March 26, 2024, among AgeX Therapeutics, Inc., the Guarantors party thereto and...
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2024
Form of Post-Merger Warrant included in Warrant Agreement dated March 19, 2024
Warrant Agreements
AgeX Therapeutics, Inc.
Biotechnology
2024
Form of Incentive Warrant included in Warrant Agreement dated March 19, 2024
Bonus & Incentive Agreements
AgeX Therapeutics, Inc.
Biotechnology
2024
Warrant Agreement, dated March 19, 2024 between AgeX Therapeutics, Inc. and Equinity Trust Company, LLC
Warrant Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2024
Sixth Amendment to Amended and Restated Convertible Promissory Note, dated February 9, 2024, between AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2024
Allonge and Fifth Amendment to Amended and Restated Convertible Promissory Note, dated November 9, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Amended and Restated Certificate of Designation of Series A Preferred Stock
Stock Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Amended and Restated Certificate of Designation of Series B Preferred Stock
Stock Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Amendment to Transition Services and Separation Agreement, dated October 31, 2023, between AgeX Therapeutics, Inc. and Michael D. West
Separation Agreements
AgeX Therapeutics, Inc.
Biotechnology
2023
Form of Pledge Agreement by AgeX Therapeutics, Inc
Pledge Agreements
AgeX Therapeutics, Inc.
Biotechnology
2023
Guaranty Agreement, dated November 9, 2023, between Reverse Bioengineering, Inc., ReCyte Therapeutics, Inc., UniverXome Bioengineering, Inc. and Juvenescence Limited
Guaranty Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Joinder Agreement, dated November 9, 2023, between Reverse Bioengineering, Inc., ReCyte Therapeutics, Inc., UniverXome Bioengineering, Inc., AgeX Therapeutics, Inc. and...
Joinder Agreements
AgeX Therapeutics, Inc.
Biotechnology
2023
Allonge and Fifth Amendment to Amended and Restated Convertible Promissory Note, dated November 9, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Form of Pledge Agreement by AgeX Therapeutics, Inc
Pledge Agreements
AgeX Therapeutics, Inc.
Biotechnology
2023
Guaranty Agreement, dated November 9, 2023, between Reverse Bioengineering, Inc., ReCyte Therapeutics, Inc., UniverXome Bioengineering, Inc. and Juvenescence Limited
Guaranty Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Joinder Agreement, dated November 9, 2023, between Reverse Bioengineering, Inc., ReCyte Therapeutics, Inc., UniverXome Bioengineering, Inc., AgeX Therapeutics, Inc. and...
Joinder Agreements
AgeX Therapeutics, Inc.
Biotechnology
2023
Letter Agreement, dated August 29, 2023, by and among AgeX Therapeutics, Inc., Serina Therapeutics, Inc. and Juvenescence Limited
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Form of Serina Therapeutics, Inc. Lock-Up Agreement
AgeX Therapeutics, Inc.
Biotechnology
2023
Form of AgeX Therapeutics, Inc. Lock-Up Agreement
AgeX Therapeutics, Inc.
Biotechnology
2023
Form of Serina Therapeutics, Inc. Stockholder Support Agreement
AgeX Therapeutics, Inc.
Biotechnology
AL
2023
Form of AgeX Therapeutics, Inc. Stockholder Support Agreement
AgeX Therapeutics, Inc.
Biotechnology
AL
2023
Agreement and Plan of Merger and Reorganization, dated August 29, 2023, by and among AgeX Therapeutics, Inc., Canaria Transaction Corporation and Serina Therapeutics, Inc
Merger Agreements
AgeX Therapeutics, Inc.
Biotechnology
AL
2023
Transition Services and Separation Agreement, dated August 9, 2023, between AgeX Therapeutics, Inc. and Michael D. West
Separation Agreements
AgeX Therapeutics, Inc.
Biotechnology
CA
2023
Consulting Agreement, dated August 9, 2023, between AgeX Therapeutics, Inc. and Joanne Hackett
Consulting Agreements
AgeX Therapeutics, Inc.
Biotechnology
CA
2023
Amendment to Secured Convertible Promissory Note, executed by AgeX Therapeutics, Inc. and Juvenescence Limited on July 31, 2023
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Fourth Amendment to Amended and Restated Secured Convertible Promissory Note, executed by AgeX Therapeutics, Inc. and Juvenescence Limited on July 31, 2023
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Registration Rights Agreement, dated July 21, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited
Registration Rights Agreements
AgeX Therapeutics, Inc.
Biotechnology
CA
2023
Exchange Agreement, dated July 21, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited
Exchange Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Form of Certificate of Designation of Series B Preferred Stock
Stock Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Form of Certificate of Designation of Series A Preferred Stock
Stock Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Third Amendment to Amended and Restated Secured Convertible Promissory Note, dated June 2, 2023, executed by AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Allonge and Second Amendment to Amended and Restated Convertible Promissory Note dated May 9, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Description of Securities
AgeX Therapeutics, Inc.
Biotechnology
2023
Subordination Agreement, dated March 15, 2023, between AgeX Therapeutics, Inc., Serina Therapeutics, Inc. and the other investors signatory thereto
Subordination Agreement
AgeX Therapeutics, Inc.
Biotechnology
WA
2023
Secured Convertible Promissory Note dated March 13, 2023, executed by AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Amended and Restated Security Agreement, dated March 13, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited
Security Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Convertible Note Purchase Agreement, dated March 15, 2023, between AgeX Therapeutics, Inc. and Serina Therapeutics, Inc
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Convertible Promissory Note, dated March 15, 2023, between AgeX Therapeutics, Inc. and Serina Therapeutics, Inc
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Third Amendment to that certain Secured Convertible Facility Agreement, dated March 30, 2020, by and between AgeX Therapeutics, Inc. and Juvenescence Limited
Facility Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2023
Reaffirmation Agreement, dated February 9, 2023, between AgeX Therapeutics, Inc. and Juvenescence Limited
AgeX Therapeutics, Inc.
Biotechnology
2023
Amended and Restated Secured Convertible Promissory Note, dated February 9, 2023, executed by AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2023
Amendment of 2017 Equity Inventive Plan
AgeX Therapeutics, Inc.
Biotechnology
2022
Security Agreement, dated February 14, 2022, between AgeX Therapeutics, Inc. and Juvenescence Limited
Security Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2022
Form of Warrant
Warrant Agreements
AgeX Therapeutics, Inc.
Biotechnology
2022
Secured Note dated February 14, 2022, executed by AgeX Therapeutics, Inc. and Juvenescence Limited
Note Agreements
AgeX Therapeutics, Inc.
Biotechnology
NY
2022
Warrant Agreement, dated February 14, 2022, between AgeX Therapeutics, Inc. and Juvenescence Limited
Warrant Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2022
Amendment No. 3 to Registration Rights Agreement, dated February 14, 2022, between AgeX Therapeutics, Inc. and Juvenescence Limited
Registration Rights Agreements
AgeX Therapeutics, Inc.
Biotechnology
CA
2022
Amendment No. 2 to Loan Facility Agreement, dated November 8, 2021, between AgeX Therapeutics, Inc. and Juvenescence Limited
Loan Agreements
AgeX Therapeutics, Inc.
Biotechnology
2021
Plan and Agreement of Merger, dated March 6, 2021, among Atlas Capital Partners Limited, GCLMS Acquisition Corporation, AgeX Therapeutics, Inc., and LifeMap Sciences, Inc
Merger Agreements
AgeX Therapeutics, Inc.
Biotechnology
CA
2021
Amendment No. 2 to Registration Rights Agreement, dated February 10, 2021, between AgeX Therapeutics, Inc. and Juvenescence Limited
Registration Rights Agreements
AgeX Therapeutics, Inc.
Biotechnology
CA
2021
Amendment No. 1 to Loan Facility Agreement, dated February 10, 2021, between AgeX Therapeutics, Inc. and Juvenescence Limited
Loan Agreements
AgeX Therapeutics, Inc.
Biotechnology
2021
Second Amendment to Secured Convertible Facility Agreement, dated November 12, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited
Facility Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2020
First Amendment to Secured Convertible Facility Agreement, dated July 21, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited
Facility Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2020
First Amendment to Warrant Agreement, dated July 21, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited, including form of warrant
Warrant Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2020
Employment Agreement, by and between AgeX Therapeutics, Inc. and Andrea E. Park, dated May 15, 2020
Employment Agreements
AgeX Therapeutics, Inc.
Biotechnology
CA
2020
Amendment No. 1 to Registration Rights Agreement, dated March 30, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited
Registration Rights Agreements
AgeX Therapeutics, Inc.
Biotechnology
CA
2020
Warrant Agreement, dated March 30, 2020, between AgeX Therapeutics, Inc. and Juvenescence Limited, including form of warrant
Warrant Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2020
Secured Convertible Facility Agreement, dated March 30, 2020, by and among AgeX Therapeutics, Inc., ReCyte Therapeutics, Inc., Reverse Bioengineering, Inc., and Juvenescence...
Facility Agreements
AgeX Therapeutics, Inc.
Biotechnology
2020
Description of Securities
AgeX Therapeutics, Inc.
Biotechnology
2020
Registration Rights Agreement, dated August 13, 2019, between AgeX Therapeutics, Inc. and Juvenescence, Ltd
Registration Rights Agreements
AgeX Therapeutics, Inc.
Biotechnology
CA
2019
Warrant Agreement, dated August 13, 2019, between AgeX Therapeutics, Inc. and Juvenescence, Ltd
Warrant Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2019
Loan Facility Agreement, dated August 13, 2019, between AgeX Therapeutics, Inc. and Juvenescence, Ltd
Loan Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2019
Warrant dated August 13, 2019
Warrant Agreements
AgeX Therapeutics, Inc.
Biotechnology
2019
Standard Sublease, dated for reference March 13, 2019, between AgeX Therapeutics, Inc. and InSite Vision, Inc
Lease Agreements
AgeX Therapeutics, Inc.
Biotechnology
2019
Compensation Agreement, dated March 1, 2019, between AgeX Therapeutics, Inc. and Russell L. Skibsted
Compensation Agreements
AgeX Therapeutics, Inc.
Biotechnology
CA
2019
Warrant Agreement, dated February 28, 2018, including form of warrant
Warrant Agreements
AgeX Therapeutics, Inc.
Biotechnology
DE
2019